US8678921011 - REIT

Taking everything into account, **SHO** scores **5** out of 10 in our fundamental rating. **SHO** was compared to 126 industry peers in the **Diversified REITs** industry. **SHO** is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. **SHO** has a valuation in line with the averages, but it does not seem to be growing.

In the past year **SHO** had a positive cash flow from operations.

Of the past 5 years **SHO** 4 years were profitable.

Looking at the **Return On Assets**, with a value of **6.09%**, **SHO** belongs to the top of the industry, outperforming **94.31%** of the companies in the same industry.

The **Return On Invested Capital** of **SHO** (**3.11%**) is better than **61.79%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 6.09% | ||

ROE | 8.85% | ||

ROIC | 3.11% |

ROA(3y)2.96%

ROA(5y)-0.4%

ROE(3y)4.32%

ROE(5y)-0.54%

ROIC(3y)N/A

ROIC(5y)N/A

With a decent **Profit Margin** value of **19.44%**, **SHO** is doing good in the industry, outperforming **72.36%** of the companies in the same industry.

Looking at the **Operating Margin**, with a value of **12.03%**, **SHO** is doing worse than **72.36%** of the companies in the same industry.

Looking at the **Gross Margin**, with a value of **61.94%**, **SHO** is doing worse than **69.11%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **SHO** has remained more or less at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 12.03% | ||

PM (TTM) | 19.44% | ||

GM | 61.94% |

OM growth 3YN/A

OM growth 5Y-5.33%

PM growth 3YN/A

PM growth 5Y-0.96%

GM growth 3Y11.34%

GM growth 5Y-0.56%

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so **SHO** is destroying value.

Compared to 5 years ago, **SHO** has less shares outstanding

The Debt to FCF ratio of **SHO** is **4.11**, which is a neutral value as it means it would take **SHO**, **4.11** years of fcf income to pay off all of its debts.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.38 | ||

Debt/FCF | 4.11 | ||

Altman-Z | 1.66 |

ROIC/WACC0.39

WACC8.02%

A Quick Ratio of **3.79** indicates that **SHO** has no problem at all paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 3.79 | ||

Quick Ratio | 3.79 |

The earnings per share for **SHO** have decreased by **-5.71%** in the last year.

The earnings per share for **SHO** have been decreasing by **-20.66%** on average. This is quite bad

The **Revenue** has grown by **8.16%** in the past year. This is quite good.

Measured over the past years, **SHO** shows a decrease in **Revenue**. The Revenue has been decreasing by **-3.17%** on average per year.

EPS 1Y (TTM)-5.71%

EPS 3YN/A

EPS 5Y-20.66%

EPS growth Q2Q-100%

Revenue 1Y (TTM)8.16%

Revenue growth 3Y54.42%

Revenue growth 5Y-3.17%

Revenue growth Q2Q-10.19%

The **Revenue** is expected to decrease by **-0.83%** on average over the next years.

EPS Next Y-22.95%

EPS Next 2Y2.61%

EPS Next 3Y-5.01%

EPS Next 5YN/A

Revenue Next Year-6.27%

Revenue Next 2Y-1.12%

Revenue Next 3Y-0.83%

Revenue Next 5YN/A

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The **Price/Earnings** ratio is **31.91**, which means the current valuation is very expensive for **SHO**.

Compared to the rest of the industry, the **Price/Earnings** ratio of **SHO** indicates a somewhat cheap valuation: **SHO** is cheaper than 60.98% of the companies listed in the same industry.

Based on the **Price/Forward Earnings** ratio of **41.41**, the valuation of **SHO** can be described as expensive.

Based on the **Price/Forward Earnings** ratio, **SHO** is valued a bit cheaper than 64.23% of the companies in the same industry.

When comparing the **Price/Forward Earnings** ratio of **SHO** to the average of the S&P500 Index (**21.67**), we can say **SHO** is valued expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 31.91 | ||

Fwd PE | 41.41 |

Based on the **Enterprise Value to EBITDA** ratio, **SHO** is valued cheaper than 83.74% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 10.83 | ||

EV/EBITDA | 10.31 |

A cheap valuation may be justified as **SHO**'s earnings are expected to decrease with **-5.01%** in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y2.61%

EPS Next 3Y-5.01%

With a **Dividend Yield** of **2.58**, **SHO** pays less dividend than the industry average, which is at **6.13**. 81.30% of the companies listed in the same industry pay a better dividend than **SHO**!

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.58% |

The dividend of **SHO** decreases each year by **-18.03%**.

The dividend of **SHO** decreased recently.

Dividend Growth(5Y)-18.03%

Div Incr Years1

Div Non Decr Years1

DP31.2%

EPS Next 2Y2.61%

EPS Next 3Y-5.01%

**SUNSTONE HOTEL INVESTORS INC**

NYSE:SHO (4/24/2024, 7:04:00 PM)

After market: 10.53 0 (0%)**10.53**

**+0.01 (+0.1%) **

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap2.14B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.58% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 31.91 | ||

Fwd PE | 41.41 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 6.09% | ||

ROE | 8.85% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 12.03% | ||

PM (TTM) | 19.44% | ||

GM | 61.94% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.31

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.38 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 3.79 | ||

Quick Ratio | 3.79 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-5.71%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y-22.95%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)8.16%

Revenue growth 3Y54.42%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y